India: Johnson & Johnson Receives Approval for VARIPULSE™ Platform, Advancing Atrial Fibrillation Treatment
Mumbai (Maharashtra) [India], June 3: Johnson & Johnson* today announced the approval of the VARIPULSE™ Platform, India's first Pulsed Field Ablation (PFA) technology that has been used to perform catheter ablation procedures for atrial fibrillation (AFib) in more than 80,000 procedures globally.2 AFib is an irregular and often rapid heartbeat caused by extra, uncoordinated electrical signals in the atria and is associated with structural changes in the heart due to underlying conditions and lifestyle factors.x, xi It significantly increases the risk of stroke, heart failure, and mortality.
BusinessWire India
Mumbai (Maharashtra) [India], June 3: Johnson & Johnson* today announced the approval of the VARIPULSE™ Platform, India's first Pulsed Field Ablation (PFA) technology that has been used to perform catheter ablation procedures for a... [17510 chars]
Published by: The Tribune
Read full article here: https://www.tribuneindia.com/news/business/first-in-india-johnson-johnson-receives-approval-for-varipulse-platform-advancing-atrial-fibrillation-treatment/
